{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T09:55:48Z","timestamp":1789725348361,"version":"4.0.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Marfan syndrome (MFS) is an autosomal dominant disease of the connective tissue, affecting mostly the skeletal, ocular and cardiovascular systems, caused by mutations in the <jats:italic>FBN1<\/jats:italic> gene. The existence of modifier genes has been postulated based on the wide clinical variability of manifestations in patients, even among those with the same <jats:italic>FBN1<\/jats:italic> mutation. Although isogenic mouse models of the disease were fundamental in dissecting the molecular mechanism of pathogenesis, they do not address the effect of genetic background on the disease phenotype. Here, we use a new mouse model, mg<jats:sup>\u0394loxPneo<\/jats:sup>, which presents different phenotype severity dependent on the genetic backgrounds, to identify genes involved in modulating MFS phenotype. F2 heterozygotes showed wide phenotypic variability, with no correlations between phenotypic severities of the different affected systems, indicating that each has its specific set of modifier genes. Individual analysis of the phenotypes, with SNP microarrays, identified two suggestive QTL each to the cardiovascular and skeletal, and one significant QTL to the skeletal phenotype. Epistatic interactions between the QTL account for 47.4% and 53.5% of variation in the skeletal and cardiovascular phenotypes, respectively. This is the first study that maps modifier loci for MFS, showing the complex genetic architecture underlying the disease.<\/jats:p>","DOI":"10.1038\/srep22426","type":"journal-article","created":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T13:20:24Z","timestamp":1456838424000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Identification of Loci Modulating the Cardiovascular and Skeletal Phenotypes of Marfan Syndrome in Mice"],"prefix":"10.1038","volume":"6","author":[{"given":"Gustavo R.","family":"Fernandes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia M. G.","family":"Massironi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lygia V.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,1]]},"reference":[{"key":"BFsrep22426_CR1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.hlc.2006.10.022","volume":"16","author":"L Ades","year":"2007","unstructured":"Ades, L. Guidelines for the diagnosis and management of Marfan syndrome. Heart Lung Circ. 16, 28\u201330 (2007).","journal-title":"Heart Lung Circ."},{"key":"BFsrep22426_CR2","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1146\/annurev.med.51.1.481","volume":"51","author":"RE Pyeritz","year":"2000","unstructured":"Pyeritz, R. E. The Marfan syndrome. Annu. Rev. Med. 51, 481\u2013510 (2000).","journal-title":"Annu. Rev. Med."},{"key":"BFsrep22426_CR3","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1086\/520125","volume":"81","author":"L Faivre","year":"2007","unstructured":"Faivre, L. et al. Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. Am. J. Hum. Genet. 81, 454\u2013466 (2007).","journal-title":"Am. J. Hum. Genet."},{"key":"BFsrep22426_CR4","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/ng1116","volume":"33","author":"ER Neptune","year":"2003","unstructured":"Neptune, E. R. et al. Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat Genet. 33, 407\u2013411 (2003).","journal-title":"Nat Genet."},{"key":"BFsrep22426_CR5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1126\/science.1124287","volume":"312","author":"JP Habashi","year":"2006","unstructured":"Habashi, J. P. et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science. 312, 117\u2013121 (2006).","journal-title":"Science."},{"key":"BFsrep22426_CR6","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/jmg.2009.072785","volume":"47","author":"BL Loeys","year":"2010","unstructured":"Loeys, B. L. et al. The revised Ghent nosology for the Marfan syndrome. J. Med. Genet. 47, 476\u2013485 (2010).","journal-title":"J. Med. Genet."},{"key":"BFsrep22426_CR7","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1093\/hmg\/ddg241","volume":"12","author":"S Hutchinson","year":"2003","unstructured":"Hutchinson, S. et al. Allelic variation in normal human FBN1 expression in a family with Marfan syndrome:a potential modifier of phenotype? Hum. Mol. Genet. 12, 2269\u20132276 (2003).","journal-title":"Hum. Mol. Genet."},{"key":"BFsrep22426_CR8","doi-asserted-by":"publisher","first-page":"e14136","DOI":"10.1371\/journal.pone.0014136","volume":"5","author":"BL Lima","year":"2010","unstructured":"Lima, B. L. et al. A new mouse model for marfan syndrome presents phenotypic variability associated with the genetic background and overall levels of Fbn1 expression. PloS one. 5, e14136 (2010).","journal-title":"PloS one."},{"key":"BFsrep22426_CR9","first-page":"246","volume":"6","author":"T Zangala","year":"2007","unstructured":"Zangala, T. Isolation of genomic DNA from mouse tails. J. Vis. Exp. 6, 246 (2007).","journal-title":"J. Vis. Exp."},{"key":"BFsrep22426_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/ng0195-31","volume":"9","author":"K Andrikopoulos","year":"1995","unstructured":"Andrikopoulos, K. et al. Targeted mutation in the col5a2 gene reveals a regulatory role for type V collagen during matrix assembly. Nat. Genet. 9, 31\u20136 (1995).","journal-title":"Nat. Genet."},{"key":"BFsrep22426_CR11","first-page":"36","volume":"11","author":"MD Abramoff","year":"2004","unstructured":"Abramoff, M. D., Magalhaes, P. J. & Ram, S. J. Image processing with ImageJ. Biophotonics International. 11(7), 36\u201342 (2004).","journal-title":"Biophotonics International."},{"key":"BFsrep22426_CR12","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1136\/thx.17.4.320","volume":"17","author":"MS Dunnill","year":"1962","unstructured":"Dunnill, M. S. Quantitative methods in the study of pulmonary pathology. Thorax. 17, 320\u201328 (1962).","journal-title":"Thorax."},{"key":"BFsrep22426_CR13","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1534\/genetics.109.105486","volume":"182","author":"A Cox","year":"2009","unstructured":"Cox, A. et al. A New Standard Genetic Map for the Mouse. Genetics. 182(4), 1335\u20131344 (2009).","journal-title":"Genetics."},{"key":"BFsrep22426_CR14","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/1756-0500-2-148","volume":"2","author":"R Donthu","year":"2009","unstructured":"Donthu, R., Lewin, H. A. & Larkin, D. M. SyntenyTracker: a tool for defining homologous synteny blocks using radiation hybrid maps and whole-genome sequence. BMC Res Notes. 2, 148 (2009).","journal-title":"BMC Res Notes."},{"key":"BFsrep22426_CR15","unstructured":"Mouse Genome Database (MGD) at the Mouse Genome Informatics. Available at http:\/\/www.informatics.jax.org. (accessed: 15th January 2016)."},{"key":"BFsrep22426_CR16","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1093\/bioinformatics\/btg112","volume":"19","author":"KW Broman","year":"2003","unstructured":"Broman, K. W., Wu, H., Sen, S. & Churchill, G. A. R\/qtl: QTL mapping in experimental crosses. Bioinformatics. 19, 889\u2013890 (2003).","journal-title":"Bioinformatics."},{"key":"BFsrep22426_CR17","doi-asserted-by":"crossref","unstructured":"Broman, K. W. & Saunak, S. A Guide to QTL Mapping with R\/qtl. (Springer, 2009).","DOI":"10.1007\/978-0-387-92125-9"},{"key":"BFsrep22426_CR18","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2134\/agronj1952.00021962004400080007x","volume":"44","author":"JN Warner","year":"1952","unstructured":"Warner, J. N. A method for estimating heritability. Agro. J. 44, 427\u2013430 (1952).","journal-title":"Agro. J."},{"key":"BFsrep22426_CR19","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/hmg\/ddr361","volume":"20","author":"C Goff","year":"2011","unstructured":"Goff, C. & Cormier-Daire, V. The ADAMTS(L) family and human genetic disorders. Hum. Mol. Genet. 20 (R2), 163\u2013167 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"BFsrep22426_CR20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1146\/annurev.genet.35.102401.090633","volume":"35","author":"TFC Mackay","year":"2001","unstructured":"Mackay, T. F. C. The Genetic Architecture of Quantitative Traits. Annu. Rev. Genet. 35, 303\u201339 (2001).","journal-title":"Annu. Rev. Genet."},{"key":"BFsrep22426_CR21","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nrg2809","volume":"11","author":"EE Eichler","year":"2010","unstructured":"Eichler, E. E. et al. Missing heritability and strategies for finding the underlying causes of complex disease. Nat. Rev. Genet. 11(6), 446\u2013450 (2010).","journal-title":"Nat. Rev. Genet."},{"key":"BFsrep22426_CR22","doi-asserted-by":"publisher","first-page":"e1002051","DOI":"10.1371\/journal.pgen.1002051","volume":"7","author":"R Makowsky","year":"2011","unstructured":"Makowsky, R. et al. Beyond Missing Heritability: Prediction of Complex Traits. PLoS Genet. 7(4), e1002051 (2011).","journal-title":"PLoS Genet."},{"key":"BFsrep22426_CR23","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1073\/pnas.1119675109","volume":"109","author":"O Zuk","year":"2012","unstructured":"Zuk, O., Hechter, E., Sunyaev, S. R. & Lander, E. S. The mystery of missing heritability: Genetic interactions create phantom heritability. Proc. Nat. Acad. Sci. 109(4), 1193\u20131198 (2012).","journal-title":"Proc. Nat. Acad. Sci."},{"key":"BFsrep22426_CR24","doi-asserted-by":"publisher","first-page":"17156","DOI":"10.1074\/jbc.M111.231571","volume":"286","author":"WE Kutz","year":"2011","unstructured":"Kutz, W. E. et al. ADAMTS10 protein interacts with fibrillin-1 and promotes its deposition in extracellular matrix of cultured fibroblasts. J. Biol. Chem. 286, 17156\u201317167 (2011).","journal-title":"J. Biol. Chem."},{"key":"BFsrep22426_CR25","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/ng0303-331","volume":"33","author":"V Kaartinen","year":"2003","unstructured":"Kaartinen, V. & Warburton, D. Fibrillin controls TGF-beta activation. Nat Genet. 33, 331\u2013332 (2003).","journal-title":"Nat Genet."},{"key":"BFsrep22426_CR26","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1172\/JCI200422715","volume":"114","author":"CM Ng","year":"2004","unstructured":"Ng, C. M. et al. TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. J Clin Invest. 114(11), 1586\u20131592 (2004).","journal-title":"J Clin Invest."},{"key":"BFsrep22426_CR27","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1093\/hmg\/ddg081","volume":"12","author":"P Whiteman","year":"2003","unstructured":"Whiteman, P. & Handford, P. A. Defective secretion of recombinant fragments of fibrillin-1: implications of protein misfolding for the pathogenesis of Marfan syndrome and related disorders. Hum Mol Genet. 12(7), 727\u2013737 (2003).","journal-title":"Hum Mol Genet."},{"key":"BFsrep22426_CR28","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1086\/302582","volume":"65","author":"I Schrijver","year":"1999","unstructured":"Schrijver, I., Liu, W., Brenn, T., Furthmayr, H. & Francke, U. Cysteine substitutions in epidermal growth factor-like domains of fibrillin-1: distinct effects on biochemical and clinical phenotypes. Am. J. Hum. Genet. 65, 1007\u20131020 (1999).","journal-title":"Am. J. Hum. Genet."},{"key":"BFsrep22426_CR29","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/hmg\/ddg099","volume":"12","author":"A Slavotinek","year":"2003","unstructured":"Slavotinek, A. Genetic modifiers in human development and malformation syndromes, including chaperone proteins. Hum Mol Genet. 12(90001), 45\u201350 (2003).","journal-title":"Hum Mol Genet."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep22426.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep22426","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep22426.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T03:56:25Z","timestamp":1672890985000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep22426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,1]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,3,21]]}},"alternative-id":["BFsrep22426"],"URL":"https:\/\/doi.org\/10.1038\/srep22426","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,1]]},"assertion":[{"value":"25 November 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22426"}}